Aayush Wellness has announced the resignation of Managing Director Naveenakumar Kunjaru, effective September 9, 2026. Disclosed via exchange filings, the departure is attributed to personal commitments, prompting the wellness firm to maintain continuity across its preventive healthcare operations while managing executive succession.
Aayush Wellness announces the resignation of Managing Director Naveenakumar Kunjaru, citing personal and family commitments.
Mumbai — Aayush Wellness Limited has officially announced that Naveenakumar Kunjaru has stepped down from his position as Managing Director. Disclosed through regulatory filings submitted to the stock exchanges on Wednesday, September 9, 2026, the leadership transition takes effect immediately. Kunjaru, who served under Director Identification Number (DIN) 07087891, tendered his formal resignation to the Board of Directors citing pressing personal and family commitments. The departure prompts the wellness and preventive healthcare firm to initiate executive adjustments as it continues its expansion across domestic consumer markets.
Board Acceptance and Regulatory Compliance Disclosures
According to official corporate disclosures filed under Regulation 30 of the Securities and Exchange Board of India ($\text{SEBI}$) Listing Obligations and Disclosure Requirements ($\text{LODR}$) Regulations, 2015, the board formally accepted Kunjaru's resignation during its review. The filing confirmed that there are no material reasons for his departure other than those outlined in his communication.
Corporate governance records note that Kunjaru maintains external board responsibilities, including serving as a Non-Executive Independent Director at Empower India Limited, where he chairs multiple oversight committees. Market analysts observe that the transition comes as Aayush Wellness scales its nutraceutical product lines and strengthens its diagnostics footprint through strategic quick-commerce partnerships.
Impact on Shareholders, Investors, and Corporate Operations
For retail shareholders and institutional investors, executive level changes require close monitoring of continuity within the company's ongoing preventive healthcare strategy. Management has indicated that core operational workflows and digital expansion initiatives will proceed as planned under existing executive frameworks while the board evaluates structural succession alternatives.
Official Sources Section
Details concerning the executive resignation, effective dates, and regulatory compliance disclosures are based on official announcements submitted to BSE India and the Metropolitan Stock Exchange of India by Aayush Wellness Limited on September 9, 2026.
Quote Section
According to officials, the board has accepted the resignation of the managing director, with operations continuing seamlessly under the existing executive management structure.
Why It Matters
Transparent reporting of C-suite transitions ensures continuous corporate governance compliance and maintains investor confidence during strategic shifts in mid-cap healthcare enterprises.
Key Facts at a Glance
Naveenakumar Kunjaru resigned as Managing Director of Aayush Wellness, effective September 9, 2026.
The resignation was attributed entirely to personal and family commitments.
Formal disclosures were submitted to BSE India pursuant to SEBI $\text{LODR}$ regulations.
The outgoing executive maintains independent board roles in other listed entities.
FAQ Section
Who resigned from Aayush Wellness Limited?
Naveenakumar Kunjaru stepped down from his role as Managing Director.
What reason was given for the resignation?
The departure was cited as resulting from personal and family commitments.
Where can stakeholders review the official resignation filings?
Complete regulatory disclosures are accessible via BSE India and corporate filings from Aayush Wellness Limited.
Source: Aayush Wellness Limited, BSE India